Literature DB >> 25728259

Hypertension: a systemic key to understanding local keloid severity.

Juri Arima1, Chenyu Huang1,2, Bernard Rosner3, Satoshi Akaishi1, Rei Ogawa1.   

Abstract

This study assessed whether hypertension, a circulating factor, influences local keloid severity. This retrospective cross-sectional study involved 304 consecutive patients (13-78 years old) with keloids who were surgically treated in our hospital between January 2011 and August 2013. Their blood pressure (BP), age and gender, and the size and number of their keloids before surgery were recorded. Ordinal logistic regression analyses showed that BP associated significantly with both keloid size and number (all p < 0.0001). Age also associated with keloid size (p < 0.0001). However, a Goodness-of-fit chi-square test showed that the prevalence of hypertension was not higher among keloid patients than in the general Japanese population. This study provides epidemiological evidence for the possibility that primary hypertension may aggravate keloids. We propose that the skin, along with the heart and liver, is a target organ of hypertension. The observations of this study, which require validation with large-scale prospective interventional trials, suggest that keloid patients should be screened for hypertension and that antihypertensive treatments may be of prophylactic and therapeutic value for skin fibrosis.
© 2015 by the Wound Healing Society.

Entities:  

Mesh:

Year:  2015        PMID: 25728259     DOI: 10.1111/wrr.12277

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  26 in total

Review 1.  Managing keloid scars: From radiation therapy to actual and potential drug deliveries.

Authors:  Chenyu Huang; Longwei Liu; Zhifeng You; Yanan Du; Rei Ogawa
Journal:  Int Wound J       Date:  2019-03-12       Impact factor: 3.315

2.  Incidence of and risk factors for incisional hernia after closure of temporary ileostomy for colorectal malignancy.

Authors:  T Kaneko; K Funahashi; M Ushigome; S Kagami; M Goto; T Koda; Y Nagashima; H Shiokawa; J Koike
Journal:  Hernia       Date:  2018-11-13       Impact factor: 4.739

3.  Keloid-associated lymphoid tissues in keloid lesions express vitamin D receptor.

Authors:  Ethan J Kilmister; Kim H Lim; Tinte Itinteang; Bede van Schaijik; Helen D Brasch; Paul F Davis; Swee T Tan
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

4.  A case-control study analyzing the association of keloids with hypertension and obesity.

Authors:  Audrey Rutherford; Donald A Glass
Journal:  Int J Dermatol       Date:  2017-05-11       Impact factor: 2.736

5.  Risk factors of recurrence after postoperative electron beam radiation therapy for keloid: Comparison of long-term local control rate.

Authors:  Hitoshi Maemoto; Shiro Iraha; Ken Arashiro; Kousei Ishigami; Fumikiyo Ganaha; Sadayuki Murayama
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-19

6.  Periauricular Keloids on Face-Lift Scars in a Patient with Facial Nerve Paralysis.

Authors:  Masayo Aoki; Satoshi Akaishi; Noriko M Matsumoto; Takuya Tsuge; Ken Kubomura; Midori Nishikawa; Shunichi Nomoto; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-25

Review 7.  Keloidal pathophysiology: Current notions.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Scars Burn Heal       Date:  2021-05-31

8.  Reconstruction after Anterior Chest Wall Keloid Resection Using Internal Mammary Artery Perforator Propeller Flaps.

Authors:  Rei Ogawa; Shimpei Ono; Satoshi Akaishi; Teruyuki Dohi; Takeshi Iimura; Junichi Nakao
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-09-29

Review 9.  Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.

Authors:  Rei Ogawa
Journal:  Int J Mol Sci       Date:  2017-03-10       Impact factor: 5.923

10.  Long non-coding RNA CACNA1G-AS1 promotes calcium channel protein expression and positively affects human keloid fibroblast migration.

Authors:  Ye Li; Xuebing Liang; Peng Wang; Xiao Long; Xiaojun Wang; Zhiqiang Meng
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.